Therapeutic Asset Ratings

603 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Clofarabine Inborn Errors Of Metabolism	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Clofarabine Hemoglobinopathy	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Clofarabine Hemophagocytic Syndrome	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Clofarabine NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Cyclophosphamide Genetic Inborn Errors of Metabolism	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Cyclophosphamide Monoclonal Gammopathy of Renal Significance	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Cyclophosphamide NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Cyclophosphamide Relapsed	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
CYCLOSPORIN A Hemophagocytic Syndrome	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
CYCLOSPORIN A Inborn Errors Of Metabolism	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
CYCLOSPORIN A NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
DARATUMUMAB Monoclonal Gammopathy of Renal Significance	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
DEXAMETHASONE Monoclonal Gammopathy of Renal Significance	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
DEXAMETHASONE Thalassemia	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
DEXAMETHASONE Beta Thalassemia	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Dostarlimab Clinical Stage: Stage II (T3-4, N-)	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Dostarlimab Stage III (Any T, N+)	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Enasidenib T-Cell Non-Hodgkin Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Enzalutamide Early Stage	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Epirubicin Refractory	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
Epirubicin Relapsed	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
ETOPOSIDE Bone Marrow Failure	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
ETOPOSIDE Genetic Inborn Errors of Metabolism	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
ETOPOSIDE Hemoglobinopathies	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
ETOPOSIDE NHL or HL	Memorial Sloan Kettering Cancer Center	P2	CCC (53)

Showing 176 to 200 of 603 assets

PreviousPage 8 of 25Next